Mineral bone density association with estrogen alpha receptor gene (ESRa) polymorphisms at postmenopausal osteoporosis

Mineral bone density association with estrogen alpha receptor gene (ESRa) polymorphisms at postmenopausal osteoporosis

Objective. To study restrict fragment length polymorphisms (RFLP) Pvull and Xbal of estrogen gene (EG) receptor sites and its association with bone mineral density (BMD). Material and methods. 96 female with osteoporosis (OP) and 60 female without OP of comparable postmenopausal age (55-83 years) we...

Full description

Bibliographic Details
Main Authors:	M Y Krylov, A. V. Grechenko, E Y Samarkina, N V Toroptsova, T A Korotkova, O A Nikitinskaya, V A Myakotkin, L I Benevolenskaya
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2005-02-01
Series:	Научно-практическая ревматология
Subjects:	osteoporosis gene-candidates estrogen receptor gene bone mineral density
Online Access:	https://rsp.mediar-press.net/rsp/article/view/686

Similar Items

Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis
by: K A Maslova, et al.
Published: (2008-06-01)

Analysis of alkaline phosphatase, soluble acid phosphatase, low density lipoprotein and vitamin D binding protein gene polymorphisms as possible gene-candidates participating in mineral bone density determination in women with primary osteoporosis in postmenopause
by: M Y Krylov, et al.
Published: (2004-06-01)

MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW
by: V A Myakotkin, et al.
Published: (2011-04-01)

Transforming growth factor β1 gene polymorphism in postmenopausal osteoporosis
by: M Y Krylov, et al.
Published: (2009-02-01)

LEPTIN A19G POLYMORPHISM AND LEPTIN RECEPTOR Gln223Arg AND Lys109Arg POLYMORPHISMSIN POSTMENOPAUSAL OSTEOPOROSIS
by: Mikhail Yur'evich Krylov, et al.
Published: (2010-10-01)

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)

Association of transforming growth factor (TGF) p1 T(861-20)C polymorphism with bone mineral density and TGFip gene expression in postmenopausal osteoporosis
by: Elena Vasilyevna Chetina, et al.
Published: (2012-04-01)

ASSOCIATION OF INTERLEUKIN-1β GENE POLYMORPHISM WITH POSTMENOPAUSAL OSTEOPOROSIS IN WOMEN IN THE RUSSIAN POPULATION
by: M. Yu. Krylov, et al.
Published: (2015-10-01)

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)

Association of Estrogen Receptor Alpha Gene XbaI and PvuII Polymorphisms with Postmenopausal Osteoporosis
by: Seza Bulca, et al.
Published: (2014-02-01)

Allele polymorphism of alkaline, acid soluble phosphatase genes and vitamin D-binding protein in postmenopausal osteoporosis
by: M Yu Krylov, et al.
Published: (2004-05-01)

Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis
by: Yunxiang Hu, et al.
Published: (2022-08-01)

Search for genetic markers determining the efficiency of therapy with bisphosphonates in Russian women with postmenopausal osteoporosis: A pilot study
by: M. Yu. Krylov, et al.
Published: (2016-10-01)

Salivary biomarkers (Vitamin D, Calcium, and Estrogen Hormone) in postmenopausal women with osteoporosis
by: Ameera Y AL-Amiry, et al.
Published: (2023-01-01)

Dual disease co-expression analysis reveals potential roles of estrogen-related genes in postmenopausal osteoporosis and Parkinson’s disease
by: Dongdong Yu, et al.
Published: (2025-01-01)

FARNESYL DIPHOSPHATE SYNTHASE (FDRS) AND GERANYLGERANYL DIPHOSPHATE SYNTHASE (GGSP1) GENE POLYMORPHISMS AND EFFICIENCY OF THERAPY WITH BISPHOSPHONATES IN RUSSIAN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2016-03-01)

Adherence to treatment with denosumab, its efficacy and safety in women with postmenopausal osteoporosis in clinical practice
by: N. V. Toroptsova, et al.
Published: (2016-01-01)

Progranulin deficiency associates with postmenopausal osteoporosis via increasing ubiquitination of estrogen receptor α
by: Guangfei Li, et al.
Published: (2025-01-01)

Prophylaxis of primary osteoporosis in women with complex drug Calcemin Advance (results of an open year’s study)
by: O A Nikitinskaya, et al.
Published: (2008-06-01)

Changes in the serum levels of estradiol and in the expression of estrogen receptor alpha in an experimental model of osteoporosis
by: Armine V. GRIGORYAN, et al.
Published: (2022-03-01)

Primary osteoporosis prophylaxis with different calcium preparations
by: N. V. Toroptsova, et al.
Published: (2005-02-01)

Assessment of genes LRP5, BVP4, TGF^l polymorphisms significance in postmenopausal osteoporosis
by: KA Myakotkin, et al.
Published: (2008-06-01)

Use of estrogen replacement therapy in menopause: Secondary prevention of osteoporosis
by: Đurica Snežana
Published: (2007-01-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

The Relationship Between Postmenopausal Osteoporosis and Autophagic Gene Polymorphisms
by: Türkan Turgay, et al.
Published: (2020-08-01)

THE EXPRESSION OF GENES ASSOCIATED WITH OSTEOBLAST DIFFERENTIATION AND THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) IN THE BLOOD OF PATIENTS WITH OSTEOPOROSIS
by: E. V. Chetina, et al.
Published: (2011-06-01)

THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
by: N. V. Toroptsova, et al.
Published: (2017-07-01)

Association of some dietary ingredients, vitamin D, estrogen, and obesity polymorphic receptor genes with bone mineral density in a sample of obese Egyptian women
by: Nayera E. Hassan, et al.
Published: (2021-02-01)

Influence of coffee consumption on bone mineral density in postmenopausal women with estrogen deficiency in menstrual history
by: Amila Kapetanović, et al.
Published: (2014-09-01)

Efficacy and safety of ibandronat tablets for treatment of postmenopausal osteoporosis
by: N. V. Toroplsova, et al.
Published: (2005-10-01)

Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis
by: Guofang Chen, et al.
Published: (2023-10-01)

The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)

Osteoporosis and its complications: treatment adherence and possibilities of its enhancement
by: O V Dobrovol'skaya, et al.
Published: (2011-09-01)

Association of PPAR-α Gene Polymorphism (rs4253778) with Osteoporosis in Postmenopausal Turkish Women
by: Şengül Tural, et al.
Published: (2023-04-01)

Investigating the association between dental age and polymorphisms in genes encoding estrogen receptors
by: Isabela Ribeiro MADALENA, et al.
Published: (2023-09-01)

OSTEOPOROSIS TREATMENT ADHERENCE: RESULTS FROM A RETROSPECTIVE COHORT STUDY
by: O. A. Nikitinskaya, et al.
Published: (2019-09-01)

TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
by: N. V. Toroptsova, et al.
Published: (2014-06-01)

Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01)

The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
by: Jing Xu, et al.
Published: (2023-07-01)

Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
by: Anna Wawrzyniak, et al.
Published: (2023-01-01)